Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in... see more

Recent & Breaking News (TSXV:VPT)

Ventripoint Hires Social Media Firm North Equities Corp.

TheNewsWire March 2, 2022

Ventripoint and at the Mazankowski Heart Institute to Collaborate to Conduct a World-First Study of the Changes in Cardiac Function during Pregnancy

TheNewsWire March 1, 2022

Ventripoint Announces Sponsorship for 24th Annual Canadian Society of Echocardiography Echo Weekend

TheNewsWire February 3, 2022

Ventripoint Appoints Dr. Gregory Skinner to Board of Clinical Advisors

TheNewsWire February 2, 2022

Ventripoint Hires Iconic Investor Relations LLC to Provide Investor Relations Services

TheNewsWire January 27, 2022

Ventripoint Successfully Completes European Commission QMS Certification Surveillance Audit

TheNewsWire January 24, 2022

Ventripoint Issues Option Grants and Reports Exercise of Options and Warrants

TheNewsWire January 21, 2022

Ventripoint Diagnostics (TSXV:VPT) uplists to OTCQB Venture Market

John Ballem  January 7, 2022

Ventripoint Announces Up-Listing to OTCQB Venture Market

TheNewsWire January 7, 2022

Ventripoint Successfully Renews QMS Certification

TheNewsWire December 29, 2021

Ventripoint Expands United Kingdom Marketing with New Distribution Partner CardioLogic

TheNewsWire December 21, 2021

Ventripoint Appoints Randy AuCoin to Board of Directors

TheNewsWire December 20, 2021

Ventripoint Receives Additional Funding to Develop Next Generation of the VMS+, Whole-Heart Analysis System

TheNewsWire December 6, 2021

Ventripoint Applauds the US Government for Establishing an Additional Payment to Doctors for Analyzing 3D Heart Scans

TheNewsWire November 29, 2021

Ventripoint Selected by Life Sciences Ontario as 2021 Success Story

TheNewsWire November 24, 2021

Ventripoint Provides Corporate Update on Market Adoption of VMS+ Whole-heart Analysis System

TheNewsWire November 22, 2021

Ventripoint Passes Audit of Manufacturing Facility for Canadian and US Markets

TheNewsWire November 9, 2021

Ventripoint Appoints Fiona Fitzgerald to the Board of Directors

TheNewsWire October 25, 2021

Ventripoint Installs VMS+ 3.0 Unit at East Midlands Congenital Heart Centre

TheNewsWire October 21, 2021

Ventripoint Diagnostics Ltd. Announces Closing of Upsized Bought Deal Offering of Units

TheNewsWire October 20, 2021